NCT05395104View on ClinicalTrials.gov

A Study to Assess the Effect of Cefiderocol on the Pharmacokinetics (PK) of Midazolam in Healthy Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

14

Participants

Timeline

Start Date

May 24, 2022

Primary Completion Date

July 13, 2022

Study Completion Date

July 13, 2022

Conditions

Healthy Volunteers

Interventions

DRUG

Midazolam

Syrup for oral administration

DRUG

Cefiderocol

Liquid for intravenous infusion

Trial Locations (1)

78217

Worldwide Clinical Trials, San Antonio

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Shionogi

INDUSTRY

NCT05395104 - A Study to Assess the Effect of Cefiderocol on the Pharmacokinetics (PK) of Midazolam in Healthy Participants | Biotech Hunter | Biotech Hunter